(Q72365244)
Statements
Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group (English)
A Arnold
J Ayoub
L Douglas
P Hoogendoorn
L Skingley
K Gelmon
V Hirsh
1 February 1994